CLQZX
Price
$12.78
Change
+$0.04 (+0.31%)
Updated
Nov 19 closing price
Net Assets
305.63M
RGACX
Price
$83.12
Change
+$0.43 (+0.52%)
Updated
Nov 19 closing price
Net Assets
327.37B
Interact to see
Advertisement

CLQZX vs RGACX

Header iconCLQZX vs RGACX Comparison
Open Charts CLQZX vs RGACXBanner chart's image
Columbia Disciplined Growth Inst
Price$12.78
Change+$0.04 (+0.31%)
VolumeN/A
Net Assets305.63M
American Funds Growth Fund of Amer R3
Price$83.12
Change+$0.43 (+0.52%)
VolumeN/A
Net Assets327.37B
CLQZX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
CLQZX vs. RGACX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLQZX is a Hold and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 327B vs. CLQZX (306M). RGACX pays higher dividends than CLQZX: RGACX (0.07) vs CLQZX (0.00). CLQZX was incepted earlier than RGACX: CLQZX (15 years) vs RGACX (24 years). RGACX (0.94) and CLQZX (0.92) have similar cost to investors . CLQZX is a more actively managed with annual turnover of: 68.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than CLQZX: RGACX (250) vs CLQZX (2000). RGACX annual gain was more profitable for investors over the last year : 6.37 vs. CLQZX (5.46). RGACX return over 5 years is better than : 32.00 vs. CLQZX (14.07).
CLQZXRGACXCLQZX / RGACX
Total Expense Ratio0.810.9486%
Annual Report Gross Expense Ratio0.920.9498%
Fund Existence15 years24 years-
Gain YTD14.36315.46093%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets306M327B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year5.466.3786%
Returns for 3 years51.6761.1185%
Returns for 5 years14.0732.0044%
Returns for 10 years34.5785.8040%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLGAX55.560.57
+1.04%
NYLI WMC Growth Class A
BIPIX62.08N/A
N/A
ProFunds Biotechnology UltraSector Inv
MSOPX31.40N/A
N/A
Morgan Stanley Inst Global Opp C
FOCPX23.89N/A
N/A
Fidelity OTC
HWMIX55.92N/A
N/A
Hotchkis & Wiley Mid-Cap Value I